Published in Blood Weekly, September 30th, 2010
For nearly a decade RemedyMD has pioneered registry tools and applications that can be leveraged by rare disease investigators and researchers, having created registries for Interstitial Lung Disease, Von Willebrand Disease, and several others. RemedyMD enables rare disease researchers and clinicians to see a 360º view of the diseases and individual subjects being researched.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.